Quality Level
agency
ChP, JPE, Ph. Eur., USP
product line
EMPROVE® ESSENTIAL
form
fine powder
particle size
180-260 μm (d50)
mp
160-240 °C
application(s)
pharmaceutical
solid formulation
shipped in
ambient
storage temp.
15-25°C
InChI
1S/C2H4O/c1-2-3/h2-3H,1H2
InChI key
IMROMDMJAWUWLK-UHFFFAOYSA-N
General description
作为Emprove® 计划的一部分,我们的原料随附完备文件,以便助力您制药和生物制药产品合规性、完整供应链透明度以及风险规避。我们的SAFC®产品线经受严格的质控程序检验并遵照适用的cGMP指南生产,提供用于生物药物和药物制剂和生产的优质产品。
Application
Features and Benefits
- 出色的表面处理作用,改善制剂外观
- 室温下也能快速制备包衣液
- 高聚合物浓度但低粘度的包衣液,缩短生产时间提高效率
- 稳定的湿气氧气屏障,有效保护对湿度敏感的API
Legal Information
存储类别
11 - Combustible Solids
wgk
WGK 1
法规信息
此项目有
使用 Emprove® 计划保持符合 GMP 要求
使用Emprove® Dossiers可加快资格认证、保持合规性并节省时间。
注意:您将进入 EmproveSuite.com。您的用户名和密码与 SigmaAldrich.com 是分开的,可能不同。
免费注册,几分钟内即可访问 Emprove® Dossiers。 升级您的订阅计划,解锁 Emprove® Suite 中的高级定制内容。
没有找到您要找的内容?访问 Emprove® 计划帮助页面。
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.